Signals, Powered By EquityPandit
Granules India has received EIR from US Food and Drug Administration (USFDA), for Chantilly unit.
USFDA has issued establishment inspection report (EIR) for Granules Pharmaceuticals, Inc facility, a wholly owned foreign subsidiary of the company which is situated at Chantilly, Virginia, USA.
Moreover, this facility was inspected by USFDA in December 2017 and there was 1 observation during the inspection. The company had responded to the observation within the stipulated time frame.
